Abstract: A health information system includes a health information data storage machine and a healthcare analytics processor configured to extract healthcare related commentary of healthcare consumers from a social media data storage machine and match portions of the healthcare related commentary to health information of the social media commentators in a combined health information data source. The healthcare analytics processor identifies relationships between consumer sentiment expressed in the social media information and consumer experiences, product usage, diagnoses and outcomes recorded in the health information. Benchmarks and measures of healthcare outcomes and treatments are generated based on matching consumer commentary and consumer sentiments with corresponding indications of actual healthcare experiences of the commentator recorded in the health information.

Abstract: A technique includes determining at least one impulse response of a modeling and migration of at least one point scatterer in a target structure and based at least in part on the impulse response(s) and a reflection amplitude image, determining a model for at least part of the target structure.

Abstract: A manufacturing cell for manufacturing a vehicle component can include an intelligent actuator, a pneumatic rotational cylinder, an arm, a laser scanner, and a controller. The arm can extend downward from the intelligent actuator to the pneumatic rotational cylinder. The laser scanner can be attached to the pneumatic rotational cylinder for movement with the pneumatic rotational cylinder. The laser scanner configured to scan at least a first object and a second object, and create profile data indicative of a 3D profile of the first object and the second object. The controller can be configured to assure that the second object is in a positive condition by using the profile data to determine the positive condition for the second object if the tolerance distance lies within a set range, and determine a flagged condition for the second object if the tolerance distance lies outside the set range.

Abstract: The present invention relates to methods of synthesizing long-chain polyunsaturated fatty acids, especially eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid, in recombinant cells such as yeast or plant cells. Also provided are recombinant cells or plants which produce long-chain polyunsaturated fatty acids. Furthermore, the present invention relates to a group of new enzymes which possess desaturase or elongase activity that can be used in methods of synthesizing long-chain polyunsaturated fatty acids.

Abstract: The present invention relates generally to the field of recombinant fatty acid synthesis, particularly in transgenic plants. The application describes genes involved in fatty acid synthesis and provides methods and vectors for the manipulation of fatty acid composition of plant oils. In particular, the invention provides constructs for achieving the integration of multiple heterologous genes involved in fatty acid synthesis into the plant genome, such that the resulting plants produce altered levels of polyunsaturated fatty acids. Also described are methods for enhancing the expression of fatty acid biosynthesis enzymes by co-expressing a silencing suppressor within the plant storage organ.

Abstract: Users of client devices can take any number of actions using applications of an application system to achieve an outcome. A monitoring system aggregates the interactions into a user interaction path. Over time, the monitoring system generates a large number of user interaction paths. The monitoring system analyzes the user interaction paths for correlation between interactions and outcomes. The monitoring system can correlate user interaction paths to generated interactions of a system interaction path. The monitoring system determines a correlation between interactions and outcomes by calculating a success factor based on an efficiency score and a prevalence score. The success factor is a measure correlation between a particular interaction of the application system and an outcome, the prevalence score is a measure of how often a particular interaction occurs, and the efficiency score is a measure of the application system performance for a particular interaction.

Abstract: This invention features compositions, methods, and kits for treating conditions associated with pathological ocular neovascularization, reducing scarring in the eye, treating dry eye, treating macular degeneration, and treating keratitis by administering a serotonin receptor agonist.

Abstract: The present invention relates to methods of synthesizing long-chain polyunsaturated fatty acids, especially eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid, in recombinant cells such as yeast or plant cells. Also provided are recombinant cells or plants which produce long-chain polyunsaturated fatty acids. Furthermore, the present invention relates to a group of new enzymes which possess desaturase or elongase activity that can be used in methods of synthesizing long-chain polyunsaturated fatty acids.

Abstract: A method includes receiving seismic data for a geologic region of the Earth; building a velocity model of the geologic region of the Earth; selecting at least one mode of multiple and corresponding travel time data from a data storage where the travel time data correspond to at least one complex ray signature in the geologic region of the Earth and are based at least in part on the velocity model; performing migration on the seismic data using at least the selected travel time data to generate processed seismic data; and rendering an image of the geologic region of the Earth to a display where the image includes at least a multiple image.

Abstract: The present disclosure provides methods for capturing recombinant collagen 7 from cell culture and methods of purifying recombinant collagen 7. Also provided are compositions comprising purified recombinant collagen 7 that may be used for administration to humans.

Abstract: The present invention relates generally to the field of recombinant fatty acid synthesis, particularly in transgenic plants. The application describes genes involved in fatty acid synthesis and provides methods and vectors for the manipulation of fatty acid composition of plant oils. In particular, the invention provides constructs for achieving the integration of multiple heterologous genes involved in fatty acid synthesis into the plant genome, such that the resulting plants produce altered levels of polyunsaturated fatty acids. Also described are methods for enhancing the expression of fatty acid biosynthesis enzymes by co-expressing a silencing suppressor within the plant storage organ.

Abstract: Implementations are described of a computing device that migrates data and software applications from a first computing device to a second computing device, in order to preserve data and other application-related customizations.

Abstract: The present invention relates to methods of synthesizing long-chain polyunsaturated fatty acids, especially eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid, in recombinant cells such as yeast or plant cells. Also provided are recombinant cells or plants which produce long-chain polyunsaturated fatty acids. Furthermore, the present invention relates to a group of new enzymes which possess desatorase or elongase activity that can be used in methods of synthesizing long-chain polyunsaturated fatty acids.

Abstract: This invention is directed to compositions, methods and kits for ameliorating or reducing pathogenesis of a disease by administering to a subject a serotonin receptor agonist.

Abstract: The present invention relates to methods of synthesizing long-chain polyunsaturated fatty acids, especially eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid, in recombinant cells such as yeast or plant cells. Also provided are recombinant cells or plants which produce long-chain polyunsaturated fatty acids. Furthermore, the present invention relates to a group of new enzymes which possess desatorase or elongase activity that can be used in methods of synthesizing long-chain polyunsaturated fatty acids.

Abstract: A spectral imaging device (12) for generating an image (13A) of a sample (10) includes (i) an image sensor (30); (ii) a tunable light source (14) that generates an illumination beam (16) that is directed at the sample (10); (iii) an optical assembly (22) that collects light from the sample (10) and forms an image of the sample (10) on the image sensor (30); and (iv) a control system (32) that controls the tunable light source (14) and the image sensor (30). During a time segment, the control system (32) (i) controls the tunable light source (14) so that the illumination beam (16) has a center wavenumber that is modulated through a first target wavenumber with a first modulation rate; and (ii) controls the image sensor (30) to capture at least one first image at a first frame rate. Further, the first modulation rate is equal to or greater than the first frame rate.

Abstract: The invention pertains to penile implants that facilitate tissue expansion while not substantially inhibiting normal anatomical movement. The implants may be made of different materials or made in different configurations such that such that a measured property at a first location on said implant is different than said same measured property at a second location on said implant.

Abstract: Implementations are described of a computing device that migrates data and software applications from a first computing device to a second computing device, in order to preserve data and other application-related customizations.

Abstract: Users of client devices can take any number of actions using applications of an application system to achieve an outcome. A monitoring system aggregates the interactions into a user interaction path. Over time, the monitoring system generates a large number of user interaction paths. The monitoring system analyzes the user interaction paths for correlation between interactions and outcomes. The monitoring system can correlate user interaction paths to generated interactions of a system interaction path. The monitoring system determines a correlation between interactions and outcomes by calculating a success factor based on an efficiency score and a prevalence score. The success factor is a measure correlation between a particular interaction of the application system and an outcome, the prevalence score is a measure of how often a particular interaction occurs, and the efficiency score is a measure of the application system performance for a particular interaction.

Abstract: The present disclosure provides methods for capturing recombinant collagen 7 from cell culture and methods of purifying recombinant collagen 7. Also provided are compositions comprising purified recombinant collagen 7 that may be used for administration to humans.